Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5719647 | The Journal of Pediatrics | 2017 | 9 Pages |
ObjectiveTo determine whether a moderate-to-large patent ductus arteriosus (PDA) is responsible for vasopressor-dependent hypotension, occurring at the end of the first postnatal week.Study designWe performed a retrospective, double cohort controlled study of infants delivered at â¤27+6 weeks' gestation (nâ=â313). From January 2004 through April 2011, all infants were treated with prophylactic indomethacin ([PINDO] epoch). From May 2011 through December 2015, no infant was treated with indomethacin until at least 8 postnatal days (conservative epoch). Echocardiograms were performed on postnatal days 6 or 7. Hypotension was managed by a predefined protocol. The primary outcome was the incidence of dopamine-dependent hypotension, defined as having received at least 6âµg/kg/min dopamine for at least 24 hours during postnatal days 4-7.ResultsAs expected, the incidence of moderate-to-large PDA at the end of the first week differed significantly between epochs (PINDOâ=â8%; conservativeâ=â64%). In multivariate analyses, infants in the PINDO epoch had a significantly lower incidence of vasopressor-dependent hypotension (11%) than infants in the conservative epoch (21%; ORâ=â0.40, 95% CI 0.20-0.82). Infants in the PINDO epoch also required less mean airway pressure, had a lower respiratory severity score, and lower mode of ventilation score than infants in the conservative epoch during postnatal days 4-7. The effects of PINDO on both the incidence of vasopressor-dependent hypotension and the need for respiratory support were no longer significant when analyses were adjusted for “presence or absence of a moderate-to-large PDA.”ConclusionPINDO decreases vasopressor-dependent hypotension and the need for respiratory support at the end of the first postnatal week. These effects are mediated by closure of the PDA.